고사머 바이오GOSS 주가

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $5 price target.

♻️ 재탕Gossamer Bio, Inc. 2026 Q1 - Results - Earnings Call Presentation

2026-05-21. The following slide deck was published by Gossamer Bio, Inc.

These stocks are moving in today's session

Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

♻️ 재탕Gossamer Bio, Inc. (GOSS) Q1 2026 Earnings Call Transcript

Gossamer Bio, Inc. (GOSS) Q1 2026 Earnings Call May 18, 2026 8:00 AM EDTCompany ParticipantsBryan Giraudo - COO & CFOFaheem Hasnain - Co-Founder, CEO,...

Let's have a look at the top gainers and losers in the middle of the day of today's session.

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Which stocks are gapping on Monday?

Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

♻️ 재탕12 Health Care Stocks Moving In Monday's Intraday Session

Gossamer Bio Reports Q1 2026 Results: Full Earnings Call Transcript

Transcript : Gossamer Bio, Inc., Q1 2026 Earnings Call, May 18, 2026

Presentation Operator MessageOperator Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Gossamer Bio Q1...

Berger Montague Reminds Gossamer Bio, Inc. (GOSS) Investors of Class Action Lawsuit Deadline

National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Gossamer Bio, Inc. on behalf of investors who purchased or acquired Gossamer shares during the period from...